NCT01736800 Phase II Trial of Chemotherapy With Temodar With Topotecan for CNS Metastasis of Solid Tumors Status WITHDRAWN Phase PHASE2
NCT01735747 Temozolomide, Nedaplatin, Vincristine, and Radiotherapy as First-line Treatment in Newly Diagnosed Primary CNS Lymphoma Status UNKNOWN Phase PHASE2
NCT01704287 Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Participants With Advanced Melanoma (MK-3475-002/P08719/KEYNOTE-002) Status COMPLETED Phase PHASE2
NCT01700569 Phase-1 Study of Folinic Acid to Modulate MGMT Gene in Glioblastoma Status TERMINATED Phase PHASE1
NCT01649830 Efficacy of Post-radiation Adjuvant Temozolomide Chemotherapy in Residue Low-grade Glioma Status RECRUITING Phase PHASE3
NCT01638546 Temozolomide With or Without Veliparib in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT01601535 Study of MLN8237 in Combination With Irinotecan and Temozolomide Status COMPLETED Phase PHASE1/PHASE2
NCT01601184 Study of Vismodegib in Combination With Temozolomide Versus Temozolomide Alone in Patients With Medulloblastomas With an Activation of the Sonic Hedgehog Pathway Status TERMINATED Phase PHASE1/PHASE2
NCT01590082 Doxycycline, Temozolomide and Ipilimumab in Melanoma Status TERMINATED Phase PHASE1/PHASE2
NCT01550224 Temozolomide Plus Vorinostat in Relapse/Refractory Acute Myeloid Leukemia (AML) Status COMPLETED Phase PHASE2
NCT01528046 Metformin in Children With Relapsed or Refractory Solid Tumors Status COMPLETED Phase PHASE1
NCT01525082 Capecitabine, Temozolomide, and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors Status COMPLETED Phase PHASE2
NCT01517776 Cilengitide and Metronomic Temozolomide for Relapsed or Refractory High Grade Gliomas or Diffuse Intrinsic Pontine Gliomas in Children and Adolescents Status TERMINATED Phase PHASE2
NCT01514201 Veliparib, Radiation Therapy, and Temozolomide in Treating Younger Patients With Newly Diagnosed Diffuse Pontine Gliomas Status COMPLETED Phase PHASE1/PHASE2
NCT01506609 Study Evaluating Efficacy And Tolerability Of Veliparib in Combination With Temozolomide (TMZ) or In Combination With Carboplatin and Paclitaxel Versus Placebo in Participants With Breast Cancer Gene (BRCA)1 and BRCA2 Mutation and Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT01505608 Randomized Efficacy Study of TPI 287 to Treat Primary Refractory or Early Relapsed Neuroblastoma Status TERMINATED Phase PHASE1/PHASE2
NCT01502241 Phase III Trial of Primary Radio- or Chemotherapy in Malignant Astrocytoma of the Elderly Status COMPLETED Phase PHASE3
NCT01480479 Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma Status COMPLETED Phase PHASE3
NCT01480050 Mibefradil Dihydrochloride and Temozolomide in Treating Patients With Recurrent Glioma Status COMPLETED Phase PHASE1
NCT01478321 Efficacy of Hypofractionated XRT w/Bev. + Temozolomide for Recurrent Gliomas Status TERMINATED Phase PHASE2